{"schema_version":"secwatch.filing_event.v1","accession":"0001425450-21-000148","form_type":"8-K","ticker":"KIDS","cik":"0001425450","company_name":"ORTHOPEDIATRICS CORP","filed_at":"2021-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.552448+00:00","generated_at":"2026-06-28T12:48:58.408675+00:00","sec_items":["1.01","5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"OrthoPediatrics director Berry retires, CEO Bailey joins board; compensation policy updated","bullets":["Bernie Berry, III retired from board Nov 3, 2021 after 12 years; no disagreement. Granted 2,119 shares and accelerated vesting.","CEO David R. Bailey appointed to fill vacancy, term until 2024; as employee director, no compensation.","Board amended director compensation policy effective Jan 1, 2022: annual stock grant changed to $75,000 value, meeting fees to $18,750/quarter.","Chairperson annual fees increased: Board, Comp, Gov committees to $5,000; Audit Committee chair to $10,000."],"urls":{"canonical":"https://secwatch.observer/filing/0001425450-21-000148","json":"https://secwatch.observer/filing/0001425450-21-000148.json","markdown":"https://secwatch.observer/filing/0001425450-21-000148.md","text":"https://secwatch.observer/filing/0001425450-21-000148.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1425450/000142545021000148/0001425450-21-000148-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1425450/000142545021000148/kids-20211102.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T12:48:58.408675+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"68ec0a6c0b","claim":"Bernie Berry, III retired as Director at ORTHOPEDIATRICS CORP.","evidence_excerpt":"Effective November 3, 2021, Bernie Berry, III has retired from the Company's Board of Directors after twelve years of service.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1425450/000142545021000148/0001425450-21-000148-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"724f44cfa7","claim":"David R. Bailey was appointed as Director at ORTHOPEDIATRICS CORP.","evidence_excerpt":"The Board has appointed David R. Bailey, the Company’s President and Chief Executive Officer, to fill the vacancy caused by Mr. Berry’s retirement to serve in the Class of Directors whose terms expire at the annual shareholder meeting in 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1425450/000142545021000148/0001425450-21-000148-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}